MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Soluble podoplanin as a biomarker in diffuse-type gastric cancer
Soluble podoplanin as a biomarker in diffuse-type gastric cancer
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Soluble podoplanin as a biomarker in diffuse-type gastric cancer
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Soluble podoplanin as a biomarker in diffuse-type gastric cancer
Soluble podoplanin as a biomarker in diffuse-type gastric cancer

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Soluble podoplanin as a biomarker in diffuse-type gastric cancer
Soluble podoplanin as a biomarker in diffuse-type gastric cancer
Journal Article

Soluble podoplanin as a biomarker in diffuse-type gastric cancer

2022
Request Book From Autostore and Choose the Collection Method
Overview
Diffuse-type gastric cancer, also known as scirrhous gastric cancer, is characterized by a larger number of stromal cells, referred to as cancer-associated fibroblasts (CAFs), than the number of cancer cells in the tissue. The present study focused on CAFs in gastric cancer and examined their potential as a blood biomarker. A total of 46 and 84 patients with gastric cancer were respectively included in a development and an independent validation cohort to assess the clinicopathological characteristics of plasma podoplanin (PDPN) levels. The prognostic impact of plasma PDPN was also investigated in the validation cohort. The cut-off value of the plasma-PDPN concentration was set to the median plasma PDPN concentration in the development cohort that was then divided into the high-PDPN and low-PDPN groups. The high-PDPN group tended to have more diffuse-type disease (P=0.079), which was further confirmed through logistic regression analysis (P=0.008). Kaplan-Meier survival estimates indicated that the recurrence-free survival rate was significantly lower in the high-PDPN group (P=0.029). In conclusion, plasma soluble PDPN was demonstrated to be a marker for diffuse gastric cancer and may reflect the prognosis of this disease.